- Home
- ICLR vs OWL Comparison
ICLR vs OWL Comparison
Compare ICLR & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- OWL
- Stock Information
- Founded
- ICLR 1990
- OWL 2020
- Country
- ICLR Ireland
- OWL United States
- Employees
- ICLR N/A
- OWL N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- OWL Investment Managers
- Sector
- ICLR Health Care
- OWL Finance
- Exchange
- ICLR Nasdaq
- OWL Nasdaq
- Market Cap
- ICLR 14.5B
- OWL 12.1B
- IPO Year
- ICLR 1998
- OWL N/A
- Fundamental
- Price
- ICLR $175.83
- OWL $18.80
- Analyst Decision
- ICLR Buy
- OWL Strong Buy
- Analyst Count
- ICLR 13
- OWL 14
- Target Price
- ICLR $210.67
- OWL $24.81
- AVG Volume (30 Days)
- ICLR 1.2M
- OWL 7.0M
- Earning Date
- ICLR 10-22-2025
- OWL 07-31-2025
- Dividend Yield
- ICLR N/A
- OWL 4.85%
- EPS Growth
- ICLR 13.11
- OWL 20.13
- EPS
- ICLR 9.73
- OWL 0.11
- Revenue
- ICLR $8,089,820,000.00
- OWL $2,618,831,000.00
- Revenue This Year
- ICLR N/A
- OWL $18.76
- Revenue Next Year
- ICLR $1.73
- OWL $22.71
- P/E Ratio
- ICLR $18.06
- OWL $164.67
- Revenue Growth
- ICLR N/A
- OWL 31.81
- 52 Week Low
- ICLR $125.10
- OWL $14.55
- 52 Week High
- ICLR $328.35
- OWL $26.73
- Technical
- Relative Strength Index (RSI)
- ICLR 57.64
- OWL 43.32
- Support Level
- ICLR $174.48
- OWL $18.34
- Resistance Level
- ICLR $181.51
- OWL $19.35
- Average True Range (ATR)
- ICLR 5.15
- OWL 0.60
- MACD
- ICLR 0.16
- OWL -0.12
- Stochastic Oscillator
- ICLR 78.82
- OWL 20.31
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.